ClinicalTrials.Veeva

Menu

Intraperitoneal Hyperthermic Chemotherapy in Epithelial Ovarian Carcinoma

G

Gustave Roussy

Status and phase

Unknown
Phase 2

Conditions

Figo Stage IIIC
Epithelial Ovarian Carcinoma

Treatments

Procedure: hyper thermic chemo + surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT00349505
CSET 1058
CHIPOVAC1

Details and patient eligibility

About

Phase II to study results and morbidity of intra peritoneal hyper-thermic chemotherapy as consolidation therapy in patients with FIGO stage IIIC epithelial ovarian carcinoma treated by surgery and a total of 6 cycles of platinum based chemotherapy.

A second look operation is performed after treatment; during this second look secondary cytoreductive surgery is accepted without bowel resection.If none or milimetric peritoneal disease is obseved an intraperitoneal chemotherapy is achieve

Sex

Female

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

epithelial ovarian carcinoma previous surgery + 6 cycles platinum based chemotherapy

Exclusion criteria

  • Patients ASA 3 patients with no residual tumor at first operation negative microscopic second look

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Annie REY; Dominique ELIAS, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems